Retention samples [Regulatives / Guidelines]

posted by dshah – India, 2021-04-13 17:07 (22 d 07:56 ago) – Posting: # 22308
Views: 1,137

(edited by dshah on 2021-04-13 17:19)

Dear Vinodvasala!

Please search in forum for previous discussions  ,  ,  . In general as per Compliance Policy for the Quantity of Bioavailability and Bioequivalence Samples Retained Under 21 CFR 320.38(c)- 30 units for Drug Products Manufactured in Single-Dose Units or 3 units for Drug Products Manufactured in Multi-Dose Units for US regulatory and 300 units for 5X testing (safer approach).
Regards,
Dshah

Complete thread:

Activity
 Admin contact
21,444 posts in 4,482 threads, 1,509 registered users;
online 4 (0 registered, 4 guests [including 3 identified bots]).
Forum time: Thursday 01:04 UTC (Europe/Vienna)

In matters of style, swim with the current;
in matters of principle, stand like a rock.    Thomas Jefferson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5